passages.id: 943
passages.type: sentence
passages.text: The use of this model may enhance patient care by targeting preventative therapies ( eg , granulocyte colony stimulating factor or PLD ) to those MBC patients most likely to experience NC during anthracycline-based chemotherapy .
entities.id: 944
entities.type: intervention
entities.text: PLD
entities.id: 945
entities.type: outcome
entities.text: NC
entities.id: 946
entities.type: participant
entities.text: MBC patients